Biomarker study for Ewing sarcoma
Part of Cancer clinical trials.
This study looks for special markers called 'biomarkers' in the blood of people with Ewing sarcoma and compares them to people without cancer. It aims to find new ways to understand and potentially monitor this tumor using tiny particles in the blood.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have or had Ewing sarcoma (any age or gender).
- You are willing to sign a consent form for the BIOVES study.
- If you do not have cancer, you must be an adult (legal age) and willing to sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study that follows people with Ewing’s sarcoma of the bone and certain “Ewing-like” tumors. It helps doctors understand the extent of disease at diagnosis and track outcomes, which may guide better planning for future care.
This study looks at the genetic (DNA) features of tumors in children, teens, and young adults with osteosarcoma, Ewing sarcoma, or synovial sarcoma. It may help researchers better understand these cancers by analyzing a fresh tumor sample and a blood sample.
This study looks at past patient records to understand what factors affect outcomes and how radiation therapy (high-energy beams to kill cancer cells) helps people with Ewing sarcoma. If you were treated for this bone cancer in the past, your data could help improve treatment for others.
This study aims to create new laboratory models to better understand sarcomas and cancers that have spread to the bone or lungs. By using donated tumor tissue and blood, researchers hope to learn how these cancers grow and develop, which could lead to better treatments in the future.
This study collects samples to find biomarkers related to bone metastases in common cancers. It might help doctors better understand why cancer spreads to bones.
This study is testing whether a blood test called ProGRP can help doctors see how well treatment is working in people with Ewing sarcoma. If you are newly diagnosed and are about to start your first treatment, this study may help improve how we track your progress.
Hear when a new Sarcoma, Ewing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.